We have collected information about Enhanced Antitumor Efficacy By Co-Delivery Of Doxorubicin And Paclitaxel for you. Follow the links to find out details on Enhanced Antitumor Efficacy By Co-Delivery Of Doxorubicin And Paclitaxel.
https://www.ncbi.nlm.nih.gov/pubmed/21807411/
Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles. Wang H(1), Zhao Y, Wu Y, Hu YL, Nan K, Nie G, Chen H. Author information: (1)CAS Key Laboratory for Biological Effects of Nanomaterials & Nanosafety, National Center for Nanoscience and Technology, Beijing 100190, China.Author: Hai Wang, Ying Zhao, Yan Wu, Yu lin Hu, Kaihui Nan, Guangjun Nie, Hao Chen
https://www.sciencedirect.com/science/article/pii/S0142961211008039
Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles Author links open overlay panel Hai Wang a Ying Zhao a Yan Wu a Yu-lin Hu b Kaihui Nan c Guangjun Nie a Hao Chen cAuthor: Hai Wang, Ying Zhao, Yan Wu, Yu lin Hu, Kaihui Nan, Guangjun Nie, Hao Chen
https://scholars.houstonmethodist.org/en/publications/enhanced-antitumor-efficacy-by-codelivery-of-doxorubicin-and-paclitaxel-with-amphiphilic-methoxy-pegplga-copolymer-nanoparticles(efb81cdd-60e1-41fa-879f-bab2b90bf6e9).html
Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles. The use of single chemotherapeutic drug has shown some limitations in anti-tumor treatment, such as development of drug resistance, high toxicity and limited regime of clinical uses.Author: Hai Wang, Ying Zhao, Yan Wu, Yu lin Hu, Kaihui Nan, Guangjun Nie, Hao Chen
http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.1001.5875&rep=rep1&type=pdf
Co-delivery of drugs Multifunctional nanoparticles Double emulsion Controlled drug release abstract The use of single chemotherapeutic drug has shown some limitations in anti-tumor treatment, such as development of drug resistance, high toxicity and limited regime of clinical uses. The combination of two
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4753416/
Feb 15, 2016 · Enhanced antitumor activity of the PEG-DOX-Cur NPs was also demonstrated in preliminary study using xenograft mice with hepatic tumors. Overall, the prodrug nanoparticle system provides a promising approach for combination therapy in cancer treatment.Author: Yumin Zhang, Cuihong Yang, Weiwei Wang, Jinjian Liu, Qiang Liu, Fan Huang, Liping Chu, Honglin Gao, ...
https://www.infona.pl/resource/bwmeta1.element.elsevier-4dff369c-5f7c-30a2-9ad0-bb5b91290f31
Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles Hai Wang , Ying Zhao , Yan Wu , …
https://link.springer.com/article/10.1208/s12249-018-1070-8
Jun 04, 2018 · Co-delivery of Metformin and Paclitaxel Via Folate-Modified pH-Sensitive Micelles for Enhanced Anti-tumor Efficacy. Yu Xiao 1,Author: Yu Xiao, Shuang Wang, Qingyu Zong, Zongning Yin
https://pubs.acs.org/doi/abs/10.1021/acsami.5b09112
Localized cancer treatments with combination drugs have recently emerged as crucial approaches for effective inhibition of tumor growth and reoccurrence. In this study, we present a new strategy for the osteosarcoma treatment by localized co-delivery of multiple drugs, including doxorubicin (DOX), cisplatin (CDDP) and methotraxate (MTX), using thermosensitive PLGA–PEG–PLGA hydrogels.Author: Hecheng Ma, Chaoliang He, Yilong Cheng, Zhiming Yang, Junting Zang, Jianguo Liu, Xuesi Chen
Searching for Enhanced Antitumor Efficacy By Co-Delivery Of Doxorubicin And Paclitaxel?
You can just click the links above. The data is collected for you.
